# EDGAR Filing Document

**Accession Number:** 0001707502
**File Stem:** 0001193125-23-022966
**Filing Date:** 2023-2
**Character Count:** 1891
**Document Hash:** f5556d9af708a553a2ef843e7dbd13c0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-022966.hdr.sgml**: 20230307

**ACCESSION NUMBER**: 0001193125-23-022966

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230202

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Solid Biosciences Inc.
- **CENTRAL INDEX KEY:** 0001707502
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **IRS NUMBER:** 900943402
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 500 RUTHERFORD AVENUE
- **STREET 2:** 3RD FLOOR
- **CITY:** CHARLESTOWN
- **STATE:** MA
- **ZIP:** 02129
- **BUSINESS PHONE:** 617-337-4680

**MAIL ADDRESS:**
- **STREET 1:** 500 RUTHERFORD AVENUE
- **STREET 2:** 3RD FLOOR
- **CITY:** CHARLESTOWN
- **STATE:** MA
- **ZIP:** 02129

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Solid Biosciences, LLC
- **DATE OF NAME CHANGE:** 20170524

February 2, 2023

**<u>VIA EDGAR SUBMISSION</u>**

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

Attention: Tim Buchmiller

Re: Solid Biosciences Inc.

Registration Statement on Form S-3

File No. 333-269424

<u>Request for Acceleration</u>

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Solid Biosciences Inc. (the "<u>Registrant</u>") hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269424), so that it may become effective at 4:30 p.m., Eastern time, on February 6, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

Very truly yours,

---

| | |
|:---|:---|
| By: | /s/ Bo Cumbo |
|  | Bo Cumbo<br> Chief Executive Officer |

---